Countries backed by high healthcare expenditure, increasing awareness of obesity, and sustained efforts in clinical adoption of advanced therapies contribute to the expansion
Katsi, V., Koutsopoulos, G., Fragoulis, C., Dimitriadis, K., & Tsioufis, K
They offer: Appetite Control: By interacting with hunger-regulating hormones, these treatments help individuals feel full longer, making it easier to consume fewer calories without constant cravings
This coordinated signaling reprogramming provides a structured framework for dissecting appetite-dependent metabolic remodeling at molecular, cellular, and systems levels within controlled research environments
It is being evaluated in Phase 3 trials for obesity and type 2 diabetes
The individual peptides have human research behind them, but high-quality studies of the specific CJC-1295 plus Ipamorelin combination are limited, and much of what exists comes from small or animal studies (Injectable Peptide Therapy review, 2026)